Fortress Biotech Inc. (FBIOP)
NASDAQ: FBIOP
· Real-Time Price · USD
6.69
-0.01 (-0.15%)
At close: May 01, 2025, 3:59 PM
6.63
-0.90%
After-hours: May 01, 2025, 04:00 PM EDT
-0.15% (1D)
| Bid | 6.45 |
| Market Cap | 52.26M |
| Revenue (ttm) | 57.67M |
| Net Income (ttm) | -48.31M |
| EPS (ttm) | -0.863 |
| PE Ratio (ttm) | -7.75 |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 7.28 |
| Volume | 1,645 |
| Avg. Volume (20D) | 12,806 |
| Open | 6.70 |
| Previous Close | 6.70 |
| Day's Range | 6.69 - 6.72 |
| 52-Week Range | 4.72 - 17.45 |
| Beta | 1.83 |
About FBIOP
Fortress Biotech, Inc., a biopharmaceutical company, develops and commercializes pharmaceutical and biotechnology products. The company markets dermatology products, such as Ximino capsules to treat only inflammatory lesions of non-nodular moderate to severe acne vulgaris; Targadox for severe acne; Exelderm cream for ringworm and jock itch symptoms; Ceracade for dry skin conditions; Luxamend for dressing and managing wounds; and Accutane capsules...
Industry Biotechnology
Sector Healthcare
IPO Date Nov 14, 2017
Employees 101
Stock Exchange NASDAQ
Ticker Symbol FBIOP
Website https://www.fortressbiotech.com
